Sep 22, 2017 12:30 pm UTC| Business
TORONTO, Sept. 22, 2017 -- North American Palladium Ltd. (“NAP” or the “Company”) (TSX:PDL) (OTC PINK:PALDF) is pleased to announce that its Lac des Iles Mine (the “Mine” or “LDI”) has met and exceeded the targeted...
Gaia to Present at the 3rd Annual B. Riley & Co. Consumer Conference on September 28, 2017
Sep 22, 2017 12:30 pm UTC| Business
BOULDER, Colo., Sept. 22, 2017 -- Gaia, Inc. (NASDAQ:GAIA), a conscious media company, has been invited to present at the 3rd Annual B. Riley Co. Consumer Conference, which is being held on September 28, 2017 at the...
Financial Institutions, Inc. Provides Update on “At-The-Market” Offering of Common Stock
Sep 22, 2017 12:30 pm UTC| Business
WARSAW, N.Y., Sept. 22, 2017 -- Financial Institutions, Inc. (NASDAQ:FISI) (the “Company”), the parent company of Five Star Bank, Scott Danahy Naylon, LLC and Courier Capital, LLC, today provided an update on the...
West Bancorporation, Inc. to Announce Quarterly Results, Hold Conference Call
Sep 22, 2017 12:30 pm UTC| Business
WEST DES MOINES, Iowa, Sept. 22, 2017 -- West Bancorporation, Inc. (Nasdaq:WTBA) (the “Company”), parent company of West Bank, will report its results for the third quarter of 2017, on Thursday, October 26, 2017 before...
Acer Therapeutics to Present at the Cantor Fitzgerald Global Healthcare Conference
Sep 22, 2017 12:30 pm UTC| Business
CAMBRIDGE, Mass., Sept. 22, 2017 -- Acer Therapeutics Inc., (Nasdaq:ACER), a pharmaceutical company focused on the acquisition, development and commercialization of therapies for serious rare and ultra-rare diseases...
Edgewater Announces Extension of Stock Repurchase Program
Sep 22, 2017 12:30 pm UTC| Business
WAKEFIELD, Mass., Sept. 22, 2017 -- Edgewater Technology, Inc. (NASDAQ:EDGW), a leading consulting firm that helps business leaders drive transformational change through its unique selection of business and technology...
Affimed to Present at the LEERINK Partners Roundtable Series: Rare Disease & Immuno-Oncology
Sep 22, 2017 12:02 pm UTC| Business
Heidelberg, Germany, September 22, 2017 - Affimed N.V. (Nasdaq: AFMD), a clinical stage biopharmaceutical company focused on discovering and developing highly targeted cancer immunotherapies, announced today that Dr. Adi...